莫西沙星序贯疗法治疗社区获得性肺炎疗效分析

目的：评价莫西沙星序贯疗法治疗社区获得性肺炎的疗效。方法：对42例社区获得性肺炎（CAP）患者，采用莫西沙星治疗，静点0．4g·d^-1，持续3～5d，继之口服0．4g·d^-1，维持5～7d。结果：痊愈29例（69％），显效10例（23．8％），有效率92．8％，细菌消除率87．1％，总疗程8～12d，药物副作用较小。结论：莫西沙星序贯疗法治疗社区获得性肺炎疗效高，毒副作用小，疗程较短。

Analysis on therapeutic effect of sequential therapy of moxifloxacin in the treatment of community-acquired pneumonia

Objective： To appraise the therapeutic effect of moxifloxacin on community-acquired pneumonia. Methods： 42 cases of acute community-acquired pneumonia patients were analyzed. Moxifloxacin was intravenous dripped by 0.4 g·d^-1 for 3 to 5 days, then was taken orally by 0.4 g·d^-1 for 5 to 7 days. Results： 29 cases （69%） were cured, and 10 cases （23.8%） were mended, the effective rate was 92.8% and the bacterial eradication rate was 87.1%.The total period of treatment was 8 to 12 days, and the side-effect was slight. Conclusion： The curative effect of the sequential therapy of moxifloxacin on community-acquired pneumonia was high, the side-effect was slight and the period of treatment was short.